The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits–an attempt to interpret the Women’s Health Initiative results

A review published in Gynecological Endocrinology analyzed the Women's Health Initiative (WHI) findings on hormone replacement therapy (HRT) in postmenopausal women, focusing on the effects of conjugated equine estrogens (CEE) alone versus CEE combined with medroxyprogesterone acetate (MPA). The study highlighted that the high prevalence of metabolic syndrome among participants